GE HEALTHCARE TECHNOLOGIES INC.
NASDAQ: GEHC (GE HealthCare Technologies Inc.)
Last update: 22 hours ago83.02
1.18 (1.44%)
| Previous Close | 81.84 |
| Volume | 2,395,569 |
| Price / Earnings (Forward) | 15.01 |
| Price / Sales | 1.74 |
| Price / Book | 3.22 |
| 52 Weeks Range | |
| TTM Dividend Yield | 0.18% |
| Profit Margin | 11.03% |
| Operating Margin (TTM) | 14.78% |
| Diluted EPS (TTM) | 4.76 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Quarterly Earnings Growth (YOY) | 50.80% |
| Total Debt/Equity (MRQ) | 97.51% |
| Current Ratio (MRQ) | 0.980 |
| Operating Cash Flow (TTM) | 1.78 B |
| Levered Free Cash Flow (TTM) | 1.58 B |
| Return on Assets (TTM) | 5.87% |
| Return on Equity (TTM) | 26.44% |
News Mood
AIStockmoo Score
| Value 30% | 0.6 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | 0.6 |
| Timing 30% | 1.8 |
| AI Technical info | NA |
| Technical Oscillators info | 4.0 |
| Technical Moving Averages info | -1.5 |
| Candle Patterns info | NA |
| Sentiment 20% | 0.8 |
| Analyst Consensus info | 0.0 |
| News Mood info | 2.8 |
| Smart Money 20% | 3.2 |
| Insider Activity info | NA |
| Institutional Flow info | 4.5 |
| Short Interest info | 0.1 |
| Environment | ×0.88 |
| Macro Environment info | -1.3 |
| Sector vs Market (6M) | -13.2% |
| Pillar Agreement | ×1.25 |
| Not in score | |
| Price Volatility info | -1.4 |
| Final Score | 1.67 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | GE HealthCare Technologies Inc. | Mixed | Bullish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| GEHC | - | 0.18% | - | 3.22 |
| DXCM | - | - | - | 11.97 |
| PODD | - | - | - | 6.51 |
| CBLL | - | - | - | 9.08 |
| BWAY | - | - | - | 5.20 |
| IRMD | - | 1.51% | - | 10.64 |
Select this tab to load the latest available analysis.
|
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%). |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Value |
| % Held by Insiders | 0.28% |
| % Held by Institutions | 80.26% |
No data within this time range.
Institutions
Institutional ownership: 103.57%
| Positions | Holders | Shares |
|---|---|---|
| Increased | 584 | 45,810,983 |
| Decreased | 567 | 26,716,467 |
| New | 136 | 4,582,980 |
| Sold out | 119 | 4,142,872 |
SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.
Short Interest
| Settlement | Shares | Days to cover |
|---|---|---|
| 30 Oct 2026 | 18,256,312 | 4.9 |
| 15 Oct 2026 | 19,374,350 | 5.1 |
| 30 Sep 2026 | 18,520,401 | 4.7 |
| 15 Sep 2026 | 16,909,543 | 5.5 |
| 31 Aug 2026 | 18,955,374 | 7.5 |
| 14 Aug 2026 | 17,427,194 | 5.9 |
FINRA short interest via Nasdaq, reported twice a month.
| Date | Type | Details |
|---|---|---|
| 13 Nov 2026 | Yahoo Finance |
GE HealthCare Forms MAGNUS Neuro Alliance to Advance MRI Research
GEHC's MAGNUS Neuro Alliance aims to advance neuroscience research, expand MRI applications and develop imaging biomarkers for neurological conditions. |
| 12 Nov 2026 | Yahoo Finance |
GE HealthCare Stock Outlook: Is Wall Street Bullish or Bearish?
Despite GE HealthCare’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects. |
| 11 Nov 2026 | Yahoo Finance |
GE HealthCare: 3 Key Takeaways for Long-Term Investors
Multiyear supply contracts and higher-margin product launches may help position the company to sustain margin expansion amid industry chip shortages. |
| 10 Nov 2026 | Yahoo Finance |
GEHC Expands Vscan Air AI Capabilities With Lung Guidance & AutoAS
GE HealthCare expands Vscan Air's AI capabilities with Lung Guidance and AutoAS, enhancing cardiopulmonary assessments and point-of-care diagnostic support. |
| 10 Nov 2026 | Yahoo Finance |
GE HealthCare announces intent to establish MAGNUS Neuro Alliance to unlock new possibilities in MRI for neuroscience
CHICAGO, November 10, 2026--GE HealthCare (Nasdaq: GEHC) today announced the intent to establish a collaborative research network focused on advancing neuroscience research leveraging an ultra high-gradient head-only 3.0T MR system1. The MAGNUS2 Neuro Alliance will bring together researchers and… |
| 09 Nov 2026 | Yahoo Finance |
GE HealthCare (GEHC) Raised Full-Year Guidance. Here’s What’s Behind Its Recovery.
We recently published Forget the High-Beta Hype: 10 ‘Sleep Well at Night’ Stocks to Buy Now, and GE HealthCare Technologies (NASDAQ:GEHC) came in 8th on the list. Yahoo Finance reported that the S&P 500 fell more than 4% on Thursday, November 5, its worst day since the April 2025 tariff crash… |
| 07 Nov 2026 | Yahoo Finance |
GE HealthCare Technologies (GEHC) Led A $160 Million Cardiac Imaging Investment
GE HealthCare Technologies (NasdaqGS:GEHC) led Laza Medical's Series B round, raising US$160 million to fund AI-based cardiac imaging. The financing aims to advance robotic imaging systems for cardiac procedures using artificial intelligence tools in clinical workflows. The partners plan broader… |
| 05 Nov 2026 | Yahoo Finance |
GE HealthCare Unveils Allia Celeo to Advance Interventional Imaging
GEHC's Allia Celeo launch expands its interventional imaging portfolio with AI-powered precision, flexible workflows and predictive service capabilities. |
| 04 Nov 2026 | Yahoo Finance |
Laza Medical Raises Up to $160 Million in Series B Financing Led by GE HealthCare to Advance Intelligent Imaging for Transforming the Cath Lab
Laza Medical, Inc., a Shifamed portfolio company pioneering AI-powered robotic imaging solutions for cardiac interventions, today announced it has raised up to $160 million in Series B structured financing. GE HealthCare led the round, with participation from returning investors Unorthodox… |
| 04 Nov 2026 | Yahoo Finance |
Tampa General Hospital Expands Advanced Image-Guided Care in Clinical Hybrid Operating Room Setting With GE HealthCare Allia Moveo
Tampa General Hospital (TGH) today announced the installation of GE HealthCare's Allia™ Moveo next-generation, image-guided therapy (IGT) solution into a clinical hybrid operating room at its hospital, part of the Tampa Medical & Research District (TMRD). |
| 04 Nov 2026 | Yahoo Finance |
GEHC Q3 Earnings Call Highlights Raised Outlook and Margin Risks
GE HealthCare raises its 2026 earnings outlook on strong Q3 results, but tariff risks, fourth-quarter growth concerns and margin pressures remain in focus. |
| Show more | ||
| TTM Dividend Yield | 0.18% |
| 3Y Average Dividend Yield | 0.15% |
| Payout Ratio | 2.63% |
| Expected Next Dividend Payment | Feb 2027 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 23 Oct 2026 | 22 Sep 2026 | 13 Nov 2026 | 0.04 Cash |
| 24 Jul 2026 | 30 Jun 2026 | 14 Aug 2026 | 0.035 Cash |
| 02 Apr 2026 | 12 Feb 2026 | 15 May 2026 | 0.035 Cash |
| 09 Jan 2026 | 24 Nov 2025 | 13 Feb 2026 | 0.035 Cash |
| 24 Oct 2025 | 24 Sep 2025 | 14 Nov 2025 | 0.035 Cash |
| 25 Jul 2025 | 01 Jul 2025 | 15 Aug 2025 | 0.035 Cash |
| 25 Apr 2025 | 27 Mar 2025 | 15 May 2025 | 0.035 Cash |
| 14 Jan 2025 | 21 Nov 2024 | 14 Feb 2025 | 0.035 Cash |
| 18 Oct 2024 | 18 Sep 2024 | 15 Nov 2024 | 0.03 Cash |
| 19 Jul 2024 | 26 Jun 2024 | 15 Aug 2024 | 0.03 Cash |
| 18 Apr 2024 | 22 Mar 2024 | 15 May 2024 | 0.03 Cash |
| 12 Jan 2024 | 08 Dec 2023 | 15 Feb 2024 | 0.03 Cash |
| 19 Oct 2023 | 22 Sep 2023 | 15 Nov 2023 | 0.03 Cash |
| 20 Jul 2023 | 23 Jun 2023 | 15 Aug 2023 | 0.03 Cash |
| 22 May 2023 | 25 Apr 2023 | 15 Jun 2023 | 0.03 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2026 | 0.145 | 4 | 0.18 |
| 2025 | 0.140 | 4 | 0.17 |
| 2024 | 0.120 | 4 | 0.15 |
| 2023 | 0.090 | 3 | 0.12 |
Recent Signals candle patterns and EMA crosses
AI Technical Analysis
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |